Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Research Council grant · Finished

MIOPIC Measuring Illegal Online Pharmacies' Impact and Co-evolution

Coordinator
Instituto De Empresa SL, Spain
Runs
1 May 2023 to 31 October 2024
Status
Finished
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101101053

What the project is doing

In the project's own words, from its summary on CORDIS.

The pharma analytics market reached $60B in revenues in 2021 and is expected to grow at a 20% annual rate in the coming years. The data and business intelligence provided by pharma analytics companies around drug sales is of outmost importance for multiple stakeholders in the pharma industry (e.g., manufacturers, distributors, and regulators), who rely on this data for their decision-making. However, this data is becoming increasingly biased and myopic: it only accounts for drug sales from legal pharmacies, overlooking sales from illegal pharmacies.

This limitation is becoming more and more problematic since sales from illegal pharmacies (mainly operating online) are growing at a substantive pace. The goal of this PoC is to address this limitation through the development of a web service that will provide data and business analytics on drug sales by Illegal Online Pharmacies (IOPs). This web service will allow potential users to visualize market trends, download data, and develop customized reports on IOPs The goal of this PoC is to develop a web service API that will provide data and business analytics on drug sales by Illegal Online Pharmacies (IOPs) through a web portal.

This web service will allow potential users to visualize market trends, download data, and develop customized reports, and will be provided following a pay-per-use commercial structure. While multiple stakeholders in the pharma industry are potentially interested in this data (e.g., manufacturers, distributors, pharma analytics companies, policy-makers, and law enforcement authorities), this data is currently unavailable due to the obscure nature of IOPs’ activities.

The web service proposed in this PoC will generate such data through the algorithms designed in the ILLEGALPHARMA ERC-funded project. Accordingly, this PoC outlines the technological and commercial processes that will be implemented to transform the research generated in ILLEGALPHARMA into a business innovation with market potential.

Topics

Who is involved

OrganisationCityCountryRole
Instituto De Empresa SLMadridSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI